Simplified MSI marker panel for diagnosis of colorectal cancer

Asian Pacific Journal of Cancer Prevention

Volumn 12, Issue 8, 2011, Pages 2101-2104

  Shemirani, Atena Irani ^a   Haghighi, Mahdi Montazer ^a   Zadeh, Saman Milani ^a   Fatemi, Seyed Reza ^a   Taleghani, Mohammah Yaghoob ^a   Zali, Narges ^a   Akbari, Zahra ^a   Kashfi, Seyed Mohammad Hossein ^a   Zali, Mohammad Reza ^a  

^a SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

HNPCC; Mononucleotide markers; MSI; Sporadic colorectal cancer

Indexed keywords

EID: 84858147785     PISSN: 15137368     EISSN: 2476762X     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Aaltonen LA, Salovaara R, Kristo P, et al, (1998). Incidence of hereditary nonpolyposis colorectal cancer and the feasibility of molecular screening for the disease. New Engl J Med, 338, 1481.
2. Al-Sukhni W, AronsonM, Gallinger S (2008). Hereditary colorectal cancer syndromes: familial adenomatous polyposis and lynch syndrome. Surg Clin N Am, 88, 819-44.
3. Berginc G, Brako M, Ravnik-Glava M, et al, (2009). Screening for germline mutations of MLH1, MSH2, MSH6 and PMS2 genes in Slovenian colorectal cancer patients: implications for a population specific detection strategy of Lynch syndrome. Fam Cancer, 8, 421-9.
4. Berginc G, Glava D (2009). Rapid and accurate approach for screening of microsatellite unstable tumours using quasimonomorphic mononucleotide repeats and denaturating high performance liquid chromatography (DHPLC). Dis Markers, 26, 19-26.
5. Boland CR, Goel A (2010). Microsatellite instability in colorectal cancer. Gastroenterology, 138, 2073-87.
6. Brennetot C, Buhard O, Jourdan F, et al. (2005). Mononucleotide repeats BAT 26 and BAT 25 accurately detect MSI H tumors and predict tumor content: Implications for population screening. Int J Cancer, 113, 446-50.
7. Buhard O, Suraweera N, Lectard N, et al. (2004). Quasimonomorphic mononucleotide repeats for high-level microsatellite instability analysis. Dis Markers, 20, 251-8.
8. Domanska K, Carlsson C, Bendahl PO, et al. (2009). Knowledge about hereditary nonpolyposis colorectal cancer; mutation carriers and physicians at equal levels. BMC Med Genetics, 10, 30.
9. Haghighi MM, Javadi GR, Parivar K, et al. (2010). Frequent MSI mononucleotide markers for diagnosis of hereditary nonpolyposis colorectal cancer. Asian Pac J Cancer Prev, 11, 1033-6.
10. Haghighi MM, Vahedi M, Mohebbi SR, et al. (2009). Comparison of survival between patients with hereditary non polyposis colorectal cancer (HNPCC) and sporadic colorectal cancer. Asian Pac J Cancer Prev, 10, 497-500.
11. Hampel H, Frankel WL, Martin E, et al, (2008). Feasibility of screening for Lynch syndrome among patients with colorectal cancer. J Clin Oncol, 26, 5783-??.
12. Ionov Y, Peinado MA, Malkhosyan S, et al. (1993). Ubiquitous somatic mutations in simple repeated sequences reveal a new mechanism for colonic carcinogenesis. Nature, 363, 558-61.
13. Kristen M (2010). Current hypotheses on how microsatellite instability leads to enhanced survival of Lynch syndrome patients. Clin Development Immunol, ??, ??.
14. Laghi, L, Bianchi P, Roncalli M, et al. (2004). Revised Bethesda guidelines for hereditary nonpolyposis colorectal cancer (Lynch syndrome) and microsatellite instability. J Natl Cancer Inst, 96, 1402.
15. Lin CH, Lin JK, Chang SC, et al. (2011). Molecular profile and copy number analysis of sporadic colorectal cancer in Taiwan. J Biomed Sci, 18, 36.
16. Moghimi-Dehkordi B, Safaee A, Zali MR (2008). Prognostic factors in 1,138 Iranian colorectal cancer patients. Int J Colorect Dis, 23, 683-8.
17. Pastrello C, Baglioni S, Tibiletti MG, et al. (2005). Stability of BAT26 in tumours of hereditary nonpolyposis colorectal cancer patients with MSH2 intragenic deletion. Eur J Human Genetics, 14, 63-8.
18. Pinol, V., A. Castells, M. Andreu, et al, (2005). Accuracy of revised Bethesda guidelines, microsatellite instability, and immunohistochemistry for the identification of patients with hereditary nonpolyposis colorectal cancer. JAMA, 293.
19. Schmeler KM, Lynch HT, Chen L, et al. (2006). Prophylactic surgery to reduce the risk of gynecologic cancers in the Lynch syndrome. Obstet Gynecol Surv, 61, 319.
20. Søreide K (2007). Molecular testing for microsatellite instability and DNA mismatch repair defects in hereditary and sporadic colorectal cancers - ready for prime time? Tumor Biol, 28, 290-300.
21. Søreide K (2011). High-fidelity of five quasimonomorphic mononucleotide repeats to high-frequency microsatellite instability distribution in early-stage adenocarcinoma of the colon. Anticancer Res, 31, 967.
22. Umar A, Boland CR, Terdiman JP, et al. (2004). Revised Bethesda Guidelines for hereditary nonpolyposis colorectal cancer (Lynch syndrome) and microsatellite instability. J Natl Cancer Inst, 96, 261.
23. Vasen HFA, Möslein G, Alonso A, et al. (2007). Guidelines for the clinical management of Lynch syndrome (hereditary non-polyposis cancer). J Med Genetics, 44, 353.